All In MedTech

Device Trial Radar · NCT04194073

NightOwl SpO2 Calibration Study

Last checked: Nov 19, 2026Latest source record: Dec 11, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

12

Planned (sponsor's estimate)

Start

Dec 7, 2019

Primary completion

Jan 2020

Study completion Jan 2020

Sponsor

Lead sponsor
Ectosense NVNot on our public-company list
Sponsor type
Industry
First posted
Dec 11, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Calibration of a software module that computes Oxygen saturation(SpO2) based on photoplethysmography (PPG) traces acquired by the NightOwl reflectance-based PPG sensor which is placed on the finger. The study is designed in accordance with Medical electrical equipment - Part 2-61: Particular requirements for basic safety and essential performance of pulse oximeter equipment (ISO 80601- 2-61:2011)

Conditions

  • Pulse Oximeter Calibration

Interventions

  • Pulse oximeter calibration population (NightOwl)Device

    The NightOwl is a finger and/or forehead mounted device with, among other functions, the capability to acquire double-wavelength PPG, from which SpO2 can be derived

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A_rms determinationTime frame: Within 3 months after subject recruitment, the calibration and A_rms determination should have been performed

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CMC

    Genk, Limburg, Belgium · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.